Antibiotic Therapy for Pulmonary Exacerbations in Cystic Fibrosis—A Single-Centre Prospective Observational Study

People with cystic fibrosis experience bronchopulmonary exacerbations, leading to lung damage, lung function decline, increased mortality, and a poor health-related quality of life. To date, there are still open questions regarding the rationale for antibiotic use and the optimal duration of antibio...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarz, Carsten, Wimmer, Eliana, Holz, Frederik, Grehn, Claudia, Staab, Doris, Eschenhagen, Patience Ndidi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135273/
https://www.ncbi.nlm.nih.gov/pubmed/37107096
http://dx.doi.org/10.3390/antibiotics12040734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135273/
https://www.ncbi.nlm.nih.gov/pubmed/37107096
http://dx.doi.org/10.3390/antibiotics12040734

Ejemplares similares